Lung Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lung Cancer stocks.

Symbol Grade Name Weight

View all Lung Cancer related ETFs...

Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-05-17 CREO Fell Below 200 DMA Bearish
    2021-05-17 CREO Lower Bollinger Band Walk Weakness
    2021-05-17 ONC 50 DMA Support Bullish
    2021-05-17 ONC Hammer Candlestick Bullish
    2021-05-17 ONC Doji - Bullish? Reversal
    2021-05-17 ONC Lizard Bullish Bullish Day Trade Setup
    2021-05-17 ONC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-05-17 SCLP Narrow Range Bar Range Contraction
    2021-05-17 SCLP Lower Bollinger Band Walk Weakness

    Recent News for Lung Cancer Stocks

    Date Stock Title

    Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.The vast majority (85%) of cases of lung cancer are due to long-term tobacco smoking. About 10–15% of cases occur in people who have never smoked. These cases are often caused by a combination of genetic factors and exposure to radon gas, asbestos, second-hand smoke, or other forms of air pollution. Lung cancer may be seen on chest radiographs and computed tomography (CT) scans. The diagnosis is confirmed by biopsy which is usually performed by bronchoscopy or CT-guidance.Avoidance of risk factors, including smoking and air pollution, is the primary method of prevention. Treatment and long-term outcomes depend on the type of cancer, the stage (degree of spread), and the person's overall health. Most cases are not curable. Common treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery, whereas SCLC usually responds better to chemotherapy and radiotherapy.Worldwide in 2012, lung cancer occurred in 1.8 million people and resulted in 1.6 million deaths. This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.

    More about Lung Cancer
    Browse All Tags